Tenofovir Disoproxil Fumarate 300 mg daily

TERMINATED · PHASE2, PHASE3 · HIV Infection

Consenting participants entered tenofovir/emtricitabine oral prophylaxis trial

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.